Skip to main content

Pulmonary hypertension in thyroid diseases


The influence of thyroid hormones on cardiovascular system is well established. Thyroid diseases can effectively enhance the alteration on cardiovascular system by influencing chronotropic and inotropic actions of the heart; altering the strength and the speed of contraction, the speed of relaxation, the duration of the potential of action, and the duration of the refractory period and atrio-ventricular conduction time; modulating circulation and peripheral vascular beds. One of the more intriguing insights in the connection between thyroid diseases and cardiovascular alterations is related to the evaluation of the influence of thyroid hormones on pulmonary vascular beds. Literature reported several studies regarding the association between both hypothyroidism and hyperthyroidism and the occurrence of increased vascular pulmonary arterial pressure. Nevertheless, the pathogenetic mechanisms able to explain such relationship are not fully understood. Many doubts still persist in the comprehension of the mechanisms of pulmonary hypertension in thyroid diseases. The aim of this review was to provide possible explanation about the possible interaction between pulmonary vascular beds and thyroid function in order to evaluate the possibility of novel perspectives in the general management of patients suffering from thyroid and cardiovascular diseases.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2


  1. 1.

    H. Vargas-Uricoechea, A. Bonelo-Perdomo, C.H. Sierra-Torres, Effects of thyroid hormones on the heart. Clin. Investig. Arterioscler. 26, 296–309 (2014)

    Article  PubMed  Google Scholar 

  2. 2.

    H. Vargas-Uricoechea, C.H. Sierra-Torres, Thyroid hormones and the heart. Horm. Mol. Biol. Clin. Investig. 18, 15–26 (2014)

    CAS  PubMed  Google Scholar 

  3. 3.

    S. Mohr-Kahaly, G. Kahaly, J. Meyer, Cardiovascular effects of thyroid hormones. Z. Kardiol. 85, 219–231 (1996)

    PubMed  Google Scholar 

  4. 4.

    S. Vinzio, O. Morel, J.L. Schlienger, B. Goichot, Cellular mechanisms of thyroid hormone action. Presse. Med. 34, 1147–1152 (2005)

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    B. Kim, S.D. Carvalho-Bianco, P.R. Larsen, Thyroid hormone and adrenergic signaling in the heart. Arq. Bras. Endocrinol. Metabol. 48, 171–175 (2004)

    Article  PubMed  Google Scholar 

  6. 6.

    M. Marvisi, L. Balzarini, C. Mancini, P. Mouzakiti, Thyroid gland and pulmonary hypertension. What’s the link? Panminerva Med. 55, 93–97 (2013)

    CAS  PubMed  Google Scholar 

  7. 7.

    M. Pappas, K. Mourouzis, H. Karageorgiou, C. Tesseromatis, I. Mourouzis, G. Kostopanagiotou, C. Pantos, D.V. Cokkinos, Thyroid hormone modulates the responsiveness of rat aorta to alpha1-adrenergic stimulation: an effect due to increased activation of beta2-adrenergic signaling. Int. Angiol. 28, 474–478 (2009)

    CAS  PubMed  Google Scholar 

  8. 8.

    C. Pantos, C. Mourouzis, M. Katramadou, T. Saranteas, I. Mourouzis, H. Karageorgiou, C. Tesseromatis, G. Kostopanagiotou, P. Asimacopoulos, D.V. Cokkinos, Decreased vascular reactivity to alpha1 adrenergic stimulation in the presence of hypothyroid state: a part of an adaptive response? Int. Angiol. 25, 216–220 (2006)

    CAS  PubMed  Google Scholar 

  9. 9.

    L. Sabatino, V. Lubrano, S. Balzan, C. Kusmic, S. Del Turco, G. Iervasi, Thyroid hormone deiodinases D1, D2, and D3 are expressed in human endothelial dermal microvascular line: effects of thyroid hormones. Mol. Cell. Biochem. 399, 87–94 (2015)

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    M.M. Ciccone, G. De Pergola, M.T. Porcelli, P. Scicchitano, P. Caldarola, M. Iacoviello, G. Pietro, F. Giorgino, S. Favale, Increased carotid IMT in overweight and obese women affected by Hashimoto’s thyroiditis: an adiposity and autoimmune linkage? BMC Cardiovasc. Disord. 10, 22 (2010)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. 11.

    M. Marvisi, C. Ajolfi, G. Civardi, R. Delsignore, Thyroid dysfunction and pulmonary hypertension. Recenti Prog. Med. 95, 443–446 (2004)

    PubMed  Google Scholar 

  12. 12.

    R. Senese, P. Lasala, C. Leanza, P. de Lange, New avenues for regulation of lipid metabolism by thyroid hormones and analogs. Front. Physiol. 5, 475 (2014)

    Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    M.M. Ciccone, A. Zito, A. Ciampolillo, M. Gesualdo, P. Zaza, M. Rodio, M. Barbaro, S. Di Molfetta, P. Scicchitano, Pulmonary hypertension and Hashimoto’s thyroiditis: does a relationship exist? Endocrine 48, 621–628 (2015)

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    L. Chaker, C. Baumgartner, M.A. Ikram, A. Dehghan, M. Medici, W.E. Visser, A. Hofman, N. Rodondi, R.P. Peeters, O.H. Franco, Subclinical thyroid dysfunction and the risk of stroke: a systematic review and meta-analysis. Eur. J. Epidemiol. 29, 791–800 (2014)

    CAS  Article  PubMed  Google Scholar 

  15. 15.

    N. Galiè, M. Humbert, J.L. Vachiery, S. Gibbs, I. Lang, A. Torbicki, G. Simonneau, A. Peacock, A. Vonk Noordegraaf, M. Beghetti, A. Ghofrani, M.A. Gomez Sanchez, G. Hansmann, W. Klepetko, P. Lancellotti, M. Matucci, T. McDonagh, L.A. Pierard, P.T. Trindade, M. Zompatori, M. Hoeper, V. Aboyans, A. Vaz Carneiro, S. Achenbach, S. Agewall, Y. Allanore, R. Asteggiano, L. Paolo Badano, J. Albert Barberà, H. Bouvaist, H. Bueno, R.A. Byrne, S. Carerj, G. Castro, Ç. Erol, V. Falk, C. Funck-Brentano, M. Gorenflo, J. Granton, B. Iung, D.G. Kiely, P. Kirchhof, B. Kjellstrom, U. Landmesser, J. Lekakis, C. Lionis, G.Y. Lip, S.E. Orfanos, M.H. Park, M.F. Piepoli, P. Ponikowski, M.P. Revel, D. Rigau, S. Rosenkranz, H. Völler, J. Luis Zamorano, ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37, 67–119 (2015)

    Article  PubMed  Google Scholar 

  16. 16.

    D.B. Badesch, K.M. Wynne, S. Bonvallet, N.F. Voelkel, C. Ridgway, B.M. Groves, Hypothyroidism and primary pulmonary hypertension: an autoimmune pathogenetic link? Ann. Intern. Med. 119, 44–46 (1993)

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    R.G. Chin, J. Fisher, Hypothyroidism and pulmonary hypertension: observation and speculation. Cardiovasc. Rev. Rep. 9, 789–796 (1986)

    Google Scholar 

  18. 18.

    A.L. Curnock, R.A. Dweik, B.H. Higgins, H.F. Saadi, A.C. Arroliga, High prevalence of hypothyroidism in patients with primary pulmonary hypertension. Am. J. Med. Sci. 318, 289–292 (1999)

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    J.W. Chu, P.N. Kao, J.L. Faul, R.L. Doyle, High Prevalence of autoimmune thyroid disease in pulmonary arterial hypertension. Chest 122, 1668–1673 (2002)

    Article  PubMed  Google Scholar 

  20. 20.

    J.H. Li, R.E. Safford, J.F. Aduen, M.G. Heckman, J.E. Crook, C.D. Burger, Pulmonary hypertension and thyroid disease. Chest 132, 793–797 (2007)

    Article  PubMed  Google Scholar 

  21. 21.

    M. Satoh, K. Aso, T. Nakayama, K. Naoi, S. Ikehara, Y. Uchino, H. Shimada, S. Takatsuki, H. Matsuura, T. Saji, Autoimmune thyroid disease in children and adolescents with idiopathic pulmonary arterial hypertension. Circ. J. 74, 371–374 (2010)

    CAS  Article  PubMed  Google Scholar 

  22. 22.

    I. Klein, S. Danzi, Thyroid disease and the heart. Circulation 116, 1725–1735 (2007)

    Article  PubMed  Google Scholar 

  23. 23.

    Ichiki, T.: Thyroid hormone and vascular remodeling. J Atheroscler Thromb. Nov 11. [Epub ahead of print] (2015)

  24. 24.

    S. Wieshammer, F.S. Keck, H. Seibold, U. Loos, V. Hombach, E.F. Pfeiffer, Acute hypothyroidism has no effect on pulmonary vascular resistance. Klin. Wochenschr. 67, 530–534 (1989)

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    C.C. Costa, M. Medeiros, K. Watanabe, P. Martin, T.L. Skare, Hashimoto thyroiditis may be associated with a subset of patients with systemic sclerosis with pulmonary hypertension. Rev. Bras. Reumatol. 54, 366–370 (2014)

    Article  PubMed  Google Scholar 

  26. 26.

    M.R. Nicolls, L. Taraseviciene-Stewart, P.R. Rai, D.B. Badesch, N.F. Voelkel, Autoimmunity and pulmonary hypertension: a perspective. Eur. Respir. J. 26, 1110–1118 (2005)

    CAS  Article  PubMed  Google Scholar 

  27. 27.

    J.M. Oldham, D. Kumar, C. Lee, S.B. Patel, S. Takahashi-Manns, C. Demchuk, M.E. Strek, I. Noth, Thyroid disease is prevalent and predicts survival in patients with idiopathic pulmonary fibrosis. Chest 148, 692–700 (2015)

    Article  PubMed  PubMed Central  Google Scholar 

  28. 28.

    L. Sweeney, N.F. Voelkel, Estrogen exposure, obesity and thyroid disease in women with severe pulmonary hypertension. Eur. J. Med. Res. 14, 433–442 (2009)

    Article  PubMed  PubMed Central  Google Scholar 

  29. 29.

    L. Siemińska, C. Wojciechowska, K. Walczak, A. Borowski, B. Marek, M. Nowak, D. Kajdaniuk, W. Foltyn, B. Kos-Kudła, Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6. Endokrynol Pol. 66, 394–403 (2015)

    Article  PubMed  Google Scholar 

  30. 30.

    A. Tvarijonaviciute, L. Jaillardon, J.J. Cerón, B. Siliart, Effects of thyroxin therapy on different analytes related to obesity and inflammation in dogs with hypothyroidism. Vet. J. 196, 71–75 (2013)

    CAS  Article  PubMed  Google Scholar 

  31. 31.

    F. Vargas, J.M. Moreno, I. Rodriguez-Gomez, R. Wangensteen, A. Osuna, M. Alvarez-Guerra, J. Garcia-Estan, Vascular and renal function in experimental thyroid disorders. Eur. J. Endocrinol. 154, 197–212 (2006)

    CAS  Article  PubMed  Google Scholar 

  32. 32.

    L. Osmak-Tizon, M. Poussier, Y. Cottin, L. Rochette, Non-genomic actions of thyroid hormones: molecular aspects. Arch. Cardiovasc. Dis. 107, 207–211 (2014)

    Article  PubMed  Google Scholar 

  33. 33.

    P.J. Davis, F.B. Davis, Nongenomic actions of thyroid hormone. Thyroid 6, 497–504 (1996)

    CAS  Article  PubMed  Google Scholar 

  34. 34.

    R. Vicinanza, G. Coppotelli, C. Malacrino, T. Nardo, B. Buchetti, L. Lenti, F.S. Celi, S. Scarpa, Oxidized low-density lipoproteins impair endothelial function by inhibiting non-genomic action of thyroid hormone-mediated nitric oxide production in human endothelial cells. Thyroid 23, 231–238 (2013)

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  35. 35.

    L.H. Duntas, E. Mantzou, D.A. Koutras, Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism. Thyroid 12, 1003–1007 (2002)

    CAS  Article  PubMed  Google Scholar 

  36. 36.

    T. Ittermann, S.E. Baumeister, H. Völzke, C. Wasner, U. Schminke, H. Wallaschofski, M. Nauck, J. Lüdemann, Are serum TSH levels associated with oxidized low-density lipoprotein? Results from the Study of Health in Pomerania. Clin. Endocrinol. (Oxf). 76, 526–532 (2012)

    CAS  Article  PubMed  Google Scholar 

  37. 37.

    T. Diekman, P.N. Demacker, J.J. Kastelein, A.F. Stalenhoef, W.M. Wiersinga, Increased oxidizability of low-density lipoproteins in hypothyroidism. J. Clin. Endocrinol. Metab. 83, 1752–1755 (1998)

    CAS  Article  PubMed  Google Scholar 

  38. 38.

    A.S. Tamajusuku, M.A. Carrillo-Sepúlveda, E. Braganhol, M.R. Wink, J.J. Sarkis, M.L. Barreto-Chaves, A.M. Battastini, Activity and expression of ecto-5′-nucleotidase/CD73 are increased by thyroid hormones in vascular smooth muscle cells. Mol. Cell. Biochem. 289, 65–72 (2006)

    CAS  Article  PubMed  Google Scholar 

  39. 39.

    S. Taddei, N. Caraccio, A. Virdis, A. Dardano, D. Versari, L. Chiadoni, A. Salvetti, E. Ferrannini, F. Monzani, Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J. Clin. Endocrinol. Metab. 88, 3731–3737 (2003)

    CAS  Article  PubMed  Google Scholar 

  40. 40.

    K. Fukuyama, T. Ichiki, I. Imayama, H. Ohtsubo, H. Ono, Y. Hashiguchi, A. Takeshita, K. Sunagawa, Thyroid hormone inhibits vascular remodeling through suppression of cAMP response element binding protein activity. Arterioscler. Thromb. Vasc. Biol. 26, 2049–2055 (2006)

    CAS  Article  PubMed  Google Scholar 

  41. 41.

    M. Hostiuc, G.C. Curca, D. Dermengiu, C. Sinescu, S. Hostiuc, Can subclinical hypothyroidism explain some sudden deaths due to pulmonary embolism without evident risk factors? Med. Hypotheses 76, 855–857 (2011)

    CAS  Article  PubMed  Google Scholar 

  42. 42.

    C. Erem, O. Ucuncu, M. Yilmaz, M. Kocak, I. Nuhoglu, H.O. Ersoz, Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism. Endocrine 35, 75–80 (2009)

    CAS  Article  PubMed  Google Scholar 

  43. 43.

    O. Araz, E. Yilmazel Ucar, A. Yalcin, D. Pulur, H. Acemoglu, H. Tas, L. Saglam, M. Akgun, A. Mirici, The incidence and severity of pulmonary hypertension in obstructive sleep apnea with hypothyroidism. Med. Sci. Monit. 19, 883–887 (2013)

    Article  PubMed  PubMed Central  Google Scholar 

  44. 44.

    M. Marvisi, M. Brianti, G. Marani, R. Del Borello, M.L. Bortesi, A. Guariglia, Hyperthyroidism and pulmonary hypertension. Respir. Med. 96, 215–220 (2002)

    CAS  Article  PubMed  Google Scholar 

  45. 45.

    M. Marvisi, P. Zambrelli, M. Brianti, G. Civardi, R. Lampugnani, R. Delsignore, Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy. Eur. J. Intern. Med. 17, 267–271 (2006)

    Article  PubMed  Google Scholar 

  46. 46.

    R. Alcázar, M. Rey, P. de Sequera, R. Alegre, A. Rovira, C. Caramelo, The reversibility of pulmonary hypertension associated with autoimmune hyperthyroidism. Rev. Esp. Cardiol. 48, 142–144 (1995)

    PubMed  Google Scholar 

  47. 47.

    C.W. Siu, X.H. Zhang, C. Yung, A.W. Kung, C.P. Lau, H.F. Tse, Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective echocardiographic study. J. Clin. Endocrinol. Metab. 92, 1736–1742 (2007)

    CAS  Article  PubMed  Google Scholar 

  48. 48.

    J. Mercé, S. Ferrás, C. Oltra, E. Sanz, J. Vendrell, I. Simón, M. Camprubí, A. Bardají, C. Ridao, Cardiovascular abnormalities in hyperthyroidism: a prospective Doppler echocardiographic study. Am. J. Med. 118, 126–131 (2005)

    Article  PubMed  Google Scholar 

  49. 49.

    C.M. Trapp, R.W. Elder, A.T. Gerken, A.B. Sopher, S. Lerner, G.S. Aranoff, E.B. Rosenzweig, Pediatric pulmonary arterial hypertension and hyperthyroidism: a potentially fatal combination. J. Clin. Endocrinol. Metab. 97, 2217–2222 (2012)

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  50. 50.

    R. Obeid, V.K. Kalra, P. Arora, F. Quist, K.C. Moltz, N.S. Chouthai, Neonatal thyrotoxicosis presenting as persistent pulmonary hypertension. BMJ Case Rep. (2012). doi: 10.1136/bcr.02.2012.5939

  51. 51.

    D. O’Donovan, C. McMahon, C. Costigan, P. Oslizlok, D. Duff, Reversible pulmonary hypertension in neonatal Graves disease. Ir. Med. J. 90, 147–148 (1997)

    PubMed  Google Scholar 

  52. 52.

    B. Agraou, O. Tricot, A. Strecker, R. Bresson, F. Leroy, P. Langlois, B. Lauwerier, J.J. Dujardin, Hyperthyroidism associated with pulmonary hypertension. Arch. Mal. Coeur Vaiss. 89, 765–768 (1996)

    CAS  PubMed  Google Scholar 

  53. 53.

    G.A. Brent, Clinical practice. Graves’ disease. N Engl J Med. 358, 2594–2605 (2008)

    CAS  Article  PubMed  Google Scholar 

  54. 54.

    H. Ikram, The nature and prognosis of thyrotoxic heart disease. Q. J. Med. 54, 19–28 (1985)

    CAS  PubMed  Google Scholar 

  55. 55.

    M.O. Hegazi, S. Ahmed, Atypical clinical manifestations of Graves’ disease: an analysis in depth. J. Thyroid Res. 2012, 768019 (2012)

    Article  PubMed  Google Scholar 

  56. 56.

    M.O. Hegazi, A. El Sayed, H. El Ghoussein, Pulmonary hypertension responding to hyperthyroidism treatment. Respirology 13, 923–925 (2008)

    Article  PubMed  Google Scholar 

  57. 57.

    Y. Paran, A. Nimrod, Y. Goldin, D. Justo, Pulmonary hypertension and predominant right heart failure in thyrotoxicosis. Resuscitation 69, 339–341 (2006)

    Article  PubMed  Google Scholar 

  58. 58.

    R. Di Giovambattista, Hyperthyroidism as a reversible cause of right ventricular overload and congestive heart failure. Cardiovasc. Ultrasound. 6, 29 (2008)

    Article  PubMed  PubMed Central  Google Scholar 

  59. 59.

    B. Biondi, Mechanisms in endocrinology: heart failure and thyroid dysfunction. Eur. J. Endocrinol. 167, 609–618 (2012)

    CAS  Article  PubMed  Google Scholar 

  60. 60.

    V.H. Tam, L.M. Fung, Severe right heart failure in two patients with thyrotoxicosis. Hong Kong Med. J. 14, 321–323 (2008)

    PubMed  Google Scholar 

  61. 61.

    A. Yazar, O. Döven, S. Atis, R. Gen, C. Pata, E.E. Yazar, A. Kanik, Systolic pulmonary artery pressure and serum uric acid levels in patients with hyperthyroidism. Arch. Med. Res. 34, 35–40 (2003)

    CAS  Article  PubMed  Google Scholar 

  62. 62.

    A. Soroush-Yari, S. Burstein, G.W. Hoo, S.M. Santiago, Pulmonary hypertension in men with thyrotoxicosis. Respiration 72, 90–94 (2005)

    Article  PubMed  Google Scholar 

  63. 63.

    T. Sugiura, S. Yamanaka, H. Takeuchi, N. Morimoto, M. Kamioka, Y. Matsumura, Autoimmunity and pulmonary hypertension in patients with Graves’ disease. Heart Vessel. 30, 642–646 (2015)

    Article  Google Scholar 

  64. 64.

    V.O. Kheyfets, L. Rios, T. Smith, T. Schroeder, J. Mueller, S. Murali, D. Lasorda, A. Zikos, J. Spotti, J.J. Reilly Jr, E.A. Finol, Patient-specific computational modeling of blood flow in the pulmonary arterial circulation. Comput. Methods Programs Biomed. 120, 88–101 (2015)

    Article  PubMed  PubMed Central  Google Scholar 

  65. 65.

    B.J. Xu, J. Chen, X. Chen, X.W. Liu, S. Fang, Q. Shu, L. Hu, S.S. Shi, L.Z. Du, L.H. Tan, High shear stress-induced pulmonary hypertension alleviated by endothelial progenitor cells independent of autophagy. World J. Pediatr. 11, 171–176 (2015)

    CAS  Article  PubMed  Google Scholar 

  66. 66.

    A. Postles, A.R. Clark, M.H. Tawhai, Dynamic blood flow and wall shear stress in pulmonary hypertensive disease. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2014, 5671–5674 (2014)

    PubMed  Google Scholar 

  67. 67.

    S. Song, A. Yamamura, H. Yamamura, R.J. Ayon, K.A. Smith, H. Tang, A. Makino, J.X. Yuan, Flow shear stress enhances intracellular Ca2 + signaling in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension. Am. J. Physiol. Cell Physiol. 307, C373–383 (2014)

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  68. 68.

    N. Dereddy, J. Huang, M. Erb, S. Guzel, J.H. Wolk, S.S. Sett, M.H. Gewitz, R. Mathew, Associated inflammation or increased flow-mediated shear stress, but not pressure alone, disrupts endothelial caveolin-1 in infants with pulmonary hypertension. Pulm. Circ. 2, 492–500 (2012)

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  69. 69.

    T. Kasahara, K. Tsunekawa, K. Seki, M. Mori, M. Murakami, Regulation of iodothyronine deiodinase and roles of thyroid hormones in human coronary artery smooth muscle cells. Atherosclerosis 186, 207–214 (2006)

    CAS  Article  PubMed  Google Scholar 

  70. 70.

    A. Al Husseini, G. Bagnato, L. Farkas, J. Gomez-Arroyo, D. Farkas, S. Mizuno, D. Kraskauskas, A. Abbate, B. Van Tassel, N.F. Voelkel, H.J. Bogaard, Thyroid hormone is highly permissive in angioproliferative pulmonary hypertension in rats. Eur. Respir. J. 41, 104–114 (2013)

    CAS  Article  PubMed  Google Scholar 

  71. 71.

    Y.J. Lai, G.J. Chang, Y.H. Yeh, J.H. Pang, C.C. Huang, W.J. Chen, Propylthiouracil attenuates experimental pulmonary hypertension via suppression of pen-2, a key component of gamma-secretase. PLoS ONE 10, e0137426 (2015)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. 72.

    F.B. Davis, S.A. Mousa, L. O’Connor, S. Mohamed, H.Y. Lin, H.J. Cao, P.J. Davis, Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface. Circ. Res. 94, 1500–1506 (2004)

    CAS  Article  PubMed  Google Scholar 

  73. 73.

    R. Thurnheer, R. Jenni, E.W. Russi, P. Greminger, R. Speich, Hyperthyroidism and pulmonary hypertension. J. Intern. Med. 242, 185–188 (1997)

    CAS  Article  PubMed  Google Scholar 

  74. 74.

    S. Vallabhajosula, S. Radhi, C. Cevik, R. Alalawi, R. Raj, K. Nugent, Hyperthyroidism and pulmonary hypertension: an important association. Am. J. Med. Sci. 342, 507–512 (2011)

    Article  PubMed  Google Scholar 

  75. 75.

    J.H. Suk, K.I. Cho, S.H. Lee, H.G. Lee, S.M. Kim, T.I. Kim, M.K. Kim, Y.K. Shong, Prevalence of echocardiographic criteria for the diagnosis of pulmonary hypertension in patients with Graves’ disease: before and after antithyroid treatment. J. Endocrinol. Invest. 34, e229–234 (2011)

    CAS  PubMed  Google Scholar 

  76. 76.

    S. Ocak, F. Feoli, J. Fastrez, D. Butenda, C. Litvine, I.M. Colin, J.P. d’Odémont, Pulmonary arterial hypertension in a patient with stage II sarcoidosis and Hashitoxicosis. Eur. Respir. Rev. 18, 125–128 (2009)

    CAS  PubMed  Google Scholar 

  77. 77.

    P. Caturegli, A. De Remigis, N.R. Rose, Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun. Rev. 13, 391–397 (2014)

    CAS  Article  PubMed  Google Scholar 

  78. 78.

    S. Rached, R.A. Athanazio, S.A. Dias Jr, C. Jardim, R. Souza, Systemic corticosteroids as first-line treatment in pulmonary hypertension associated with POEMS syndrome. J. Bras. Pneumol. 35, 804–808 (2009)

    Article  PubMed  Google Scholar 

  79. 79.

    M. Armigliato, R. Paolini, S. Aggio, S. Zamboni, M.P. Galasso, P. Zonzin, G. Cella, Hyperthyroidism as a cause of pulmonary arterial hypertension: a prospective study. Angiology 57, 600–606 (2006)

    Article  PubMed  Google Scholar 

  80. 80.

    N. Patel, W.J. Inder, C. Sullivan, G. Kaye, An audit of amiodarone-induced thyrotoxicosis—do anti-thyroid drugs alone provide adequate treatment? Heart Lung Circ. 23, 549–554 (2014)

    Article  PubMed  Google Scholar 

  81. 81.

    E. Roti, R. Minelli, E. Gardini, L. Bianconi, L.E. Braverman, Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. A possible consequence of a destructive process in the thyroid. Arch. Intern. Med. 153, 886–892 (1993)

    CAS  Article  PubMed  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Marco Matteo Ciccone.

Ethics declarations

Conflict of interest

None declared

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Scicchitano, P., Dentamaro, I., Tunzi, F. et al. Pulmonary hypertension in thyroid diseases. Endocrine 54, 578–587 (2016).

Download citation


  • Pulmonary hypertension
  • Hyperthyroidism
  • Hypothyroidism
  • Endothelial function
  • Thyroid hormones